The Investigation of Immune Checkpoint Blockades in Small Cell Lung Cancer
August 24th 2016Raffaele Califano, MD, consultant in medical oncology, The Christie Clinic, University Hospital of South Manchester, discusses the recent investigations into the use of immune checkpoint blockades in small cell lung cancer.
Watch
The Clinical Application of the HER2 Gene Amplification Data in mCRC
August 16th 2016Kanwal Raghav, MBBS, MD, assistant professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the clinical application of the data on HER2 gene amplification in patients with metastatic colorectal cancer, as well as the benefits of using a therapy that combines trastuzumab and pertuzumab.
Watch
The Mechanism of Action of Durvalumab in the Treatment of Urothelial Bladder Cancer
August 10th 2016Saeed Rafii, MD, PhD, medical director, Sarah Cannon Research Institute, United Kingdom, discusses the mechanism of action of the PD-1 antibody durvalumab in a phase I/II dose-escalation and dose-expansion study in the treatment of patients with metastatic urothelial bladder cancer. He also discusses the next steps in this line of research.
Watch
The Ongoing Research on Bevacizumab in Non-Small Cell Lung Cancer
August 10th 2016Heather Wakelee, MD, associate professor of Medicine (Oncology), Stanford University Medical Center, discusses the evolving role of bevacizumab (Avastin) in the treatment of patients with non–small cell lung cancer.
Watch
The Benefits and Risks of Bilateral Salpingo-Oophorectomy in the Treatment of Ovarian Cancer
August 10th 2016Maurie Markman, MD, president, Medicine and Science, Cancer Treatment Centers of America, discusses the benefits and risks of performing a bilateral salpingo-oophorectomy as a treatment for patients with ovarian cancer.
Watch